Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 185380
                    [Title] => Trailblazer
                    [Summary] => When Hilarion  Henares insisted on buying two  coronary stents,  Johnson & Johnson Medical Phils. managing director Bayani Santos, Jr. was placed in a quandary. "Larry Henares is an informed heart patient. At that time, he insisted on buying our  Cypher Sirolimus-eluting stent , which had not yet gotten approval from  the Bureau of Food and Drugs. We had to get a special one-time dispensation from BFAD," he said.


                    [DatePublished] => 2002-11-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1488513
                    [AuthorName] => Margaret Jao-Grey 
                    [SectionName] => Business As Usual
                    [SectionUrl] => business-as-usual
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 174812
                    [Title] => Device offers longer-term solution for coronary artery disease
                    [Summary] => A breakthrough heart device now answers the long-time woes of patients suffering from coronary artery disease (CAD). 


Johnson & Johnson Medical Phils. recently launched its Cypher Sirolimus-eluting Stent in local hospitals. This is the first and only drug-coated stent approved by the Bureau of Food and Drugs (BFAD) for treatment of narrowed coronary arteries.


An industry first, the Cypher Sirolimus-eluting Stent is a new medical device that addresses one of the most stubborn problems in coronary artery disease treatment – the potential for restenosis. 


                    [DatePublished] => 2002-09-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 174817
                    [Title] => Heart-ening news
                    [Summary] => I am yielding my space today to Ann Montemar-Oriondo.
* * *

First for the bad news. 


Did you know that the 2000 DOH Health Indicators showed that cardiovascular disease is the leading cause of mortality among Filipinos? Blame it on the stress brought about by an increasingly fast-paced lifestyle characterized by unhealthy eating habits and lack of exercise. 


                    [DatePublished] => 2002-09-05 00:00:00
                    [ColumnID] => 135221
                    [Focus] => 0
                    [AuthorID] => 1391760
                    [AuthorName] => Joanne Rae M. Ramirez
                    [SectionName] => Newsmakers
                    [SectionUrl] => newsmakers
                    [URL] => 
                )

        )

)

CYPHER

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 185380
                    [Title] => Trailblazer
                    [Summary] => When Hilarion  Henares insisted on buying two  coronary stents,  Johnson & Johnson Medical Phils. managing director Bayani Santos, Jr. was placed in a quandary. "Larry Henares is an informed heart patient. At that time, he insisted on buying our  Cypher Sirolimus-eluting stent , which had not yet gotten approval from  the Bureau of Food and Drugs. We had to get a special one-time dispensation from BFAD," he said.


                    [DatePublished] => 2002-11-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1488513
                    [AuthorName] => Margaret Jao-Grey 
                    [SectionName] => Business As Usual
                    [SectionUrl] => business-as-usual
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 174812
                    [Title] => Device offers longer-term solution for coronary artery disease
                    [Summary] => A breakthrough heart device now answers the long-time woes of patients suffering from coronary artery disease (CAD). 


Johnson & Johnson Medical Phils. recently launched its Cypher Sirolimus-eluting Stent in local hospitals. This is the first and only drug-coated stent approved by the Bureau of Food and Drugs (BFAD) for treatment of narrowed coronary arteries.


An industry first, the Cypher Sirolimus-eluting Stent is a new medical device that addresses one of the most stubborn problems in coronary artery disease treatment – the potential for restenosis. 


                    [DatePublished] => 2002-09-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 174817
                    [Title] => Heart-ening news
                    [Summary] => I am yielding my space today to Ann Montemar-Oriondo.
* * *

First for the bad news. 


Did you know that the 2000 DOH Health Indicators showed that cardiovascular disease is the leading cause of mortality among Filipinos? Blame it on the stress brought about by an increasingly fast-paced lifestyle characterized by unhealthy eating habits and lack of exercise. 


                    [DatePublished] => 2002-09-05 00:00:00
                    [ColumnID] => 135221
                    [Focus] => 0
                    [AuthorID] => 1391760
                    [AuthorName] => Joanne Rae M. Ramirez
                    [SectionName] => Newsmakers
                    [SectionUrl] => newsmakers
                    [URL] => 
                )

        )

)

abtest

Trailblazer

By Margaret Jao-Grey  | November 25, 2002 - 12:00am

When Hilarion Henares insisted on buying two coronary stents, Johnson & Johnson Medical Phils. managing director Bayani Santos, Jr. was placed in a quandary. "Larry Henares is an informed heart patient....

Business As Usual

Device offers longer-term solution for coronary artery disease

September 5, 2002 - 12:00am

A breakthrough heart device now answers the long-time woes of patients suffering from coronary artery disease (CAD). Johnson & Johnson Medical Phils. recently launched its Cypher Sirolimus-eluting Stent in...

Science and Environment

Heart-ening news

By Joanne Rae M. Ramirez | September 5, 2002 - 12:00am

I am yielding my space today to Ann Montemar-Oriondo. * * * First for the bad news. Did you know that the 2000 DOH Health Indicators showed that cardiovascular disease is the leading cause of mortality among...

Newsmakers